Skip to main content

Table 1 Demographic data of 33 patients reported in the present study and the results of antimicrobial susceptibility testing for the associated 45 carbapenemase-producing Enterobacteriaceae (CPE) isolates

From: Genomic and clinical characterisation of multidrug-resistant carbapenemase-producing ST231 and ST16 Klebsiella pneumoniae isolates colonising patients at Siriraj hospital, Bangkok, Thailand from 2015 to 2017

   Demographic data of patients Characteristic of isolated bacteria Antimicrobial susceptibility testing results
Patient No. Age group Ward Treatment Outcome Hospital mortality Strain ST Taxonomy Collection date Type MER AMK COL FOS
1 E IM COL+FOS Nonresponse Death KPCRETH01 (14) K. pneumoniae 15/12/2015 Co R R S S
       KPCRETH05 (14) K. pneumoniae 22/12/2015 Co R R S S
2 E ICU COL+PIP Nonresponse Death KPCRETH06 - K. quasipneumoniae 01/04/2016 Co R R S R
       ECCRETH01 (14) K. pneumoniae 28/01/2016 Co R R S R
3 E IM No treatment Not applicable Alive ECCRETH02 (410) E. coli 21/12/2015 Co R R S S
4 E IM No treatment Not applicable Alive KPCRETH07 (16) K. pneumoniae 08/01/2016 Co R R S S
5 E IM No treatment Not applicable Alive KPCRETH02 (16) K. pneumoniae 01/09/2016 Co R I S R
6 E IM No treatment Not applicable Death KPCRETH08 (70) K. pneumoniae 17/02/2016 Co R R S I
       KPCRETH09 (16) K. pneumoniae 23/02/2016 Co R R S I
7 E IM No treatment Not applicable Death KPCRETH10 (37) K. pneumoniae 08/02/2016 Co R R S R
8 E IM No treatment Not applicable Death KPCRETH11 (16) K. pneumoniae 17/02/2016 Co R S S R
9 OA ICU COL+TIG Superinfection Alive KPCRETH12 (16) K. pneumoniae 08/04/2016 Co R R S R
10 OA IM No treatment Not applicable Alive KPCRETH13 (16) K. pneumoniae 26/04/2016 Co R I S S
11 YA ICU No treatment Not applicable Alive KPCRETH14 (231) K. pneumoniae 11/05/2016 Co R R S I
       KPCRETH15 (231) K. pneumoniae 27/05/2016 Co R R S I
12 E ICU No treatment Not applicable Alive KPCRETH16 (231) K. pneumoniae 17/05/2016 Co R R S R
13 E ICU No treatment Not applicable Death ECCRETH03 (231) K. pneumoniae 29/04/2016 Co R R S R
14 YA IM No treatment Not applicable Alive ECCRETH04 (2003) E. coli 18/08/2016 Co R R S S
       ECCRETH05 (2003) E. coli 26/08/2016 Co R R S S
15 E IM No treatment Not applicable Alive ECCRETH06 (410) E. coli 28/11/2016 Co R S S R
       KPCRETH17 - E. hormaechei 09/12/2016 Co R S S R
16 E IM COL+FOS Response Alive KPCRETH03 (231) K. pneumoniae 30/05/2016 Co R R S R
       KPCRETH04 (231) K. pneumoniae 21/06/2016 Co R R S R
       KPCRETH26 (231) K. pneumoniae 16/08/2016 Co R R S R
17 E IM COL+FOS Response Alive KPCRETH18 (101) K. pneumoniae 09/12/2015 In R R S I
       KPCRETH19 (101) K. pneumoniae 05/01/2016 In R R S I
       KPCRETH20 (101) K. pneumoniae 12/01/2016 In R R S I
18 E ICU COL+FOS Nonresponse Death KPCRETH21 (231) K. pneumoniae 24/03/2016 In R R S R
19 YA ICU COL+ERT Response Alive KPCRETH22 (16) K. pneumoniae 07/04/2016 In R S S I
       KPCRETH23 (16) K. pneumoniae 11/05/2016 In R S S I
       KPCRETH24 (16) K. pneumoniae 18/05/2016 In R S S I
20 OA IM COL Response Death KPCRETH25 (16) K. pneumoniae 27/05/2016 In R I S I
21 OA IM COL+MER Response Alive KPCRETH27 (231) K. pneumoniae 10/06/2016 In R R S R
22 YA ICU COL+PIP Nonresponse Death KPCRETH28 (16) K. pneumoniae 16/06/2016 In R I S R
23 YA IM COL+ FOS Response Alive KPCRETH29 (14) K. pneumoniae 22/06/2016 In R R S R
24 OA IM COL+PIP Superinfection Death KPCRETH30 (14) K. pneumoniae 17/05/2016 In R S S I
25 E ICU COL+ FOS Superinfection Death KPCRETH31 (231) K. pneumoniae 24/06/2016 In R R S I
26 E IM COL+ FOS Response Alive KPCRETH32 (231) K. pneumoniae 11/08/2016 In R R S R
27 OA IM COL+FOS Superinfection Death KPCRETH33 (231) K. pneumoniae 10/10/2016 In R S S R
28 OA IM COL+ FOS Response Alive ECCRETH07 (231) K. pneumoniae 15/12/2016 In R S S S
29 OA IM COL+FOS + GEN Superinfection Death KPCTRPRTH01 (16) K. pneumoniae 05/12/2016 In R R R R
30 OA ICU COL+ LEV Superinfection Death KPCTRPRTH02 (231) K. pneumoniae 03/01/2017 In R R R R
31 E ICU COL+FOS + GEN Response Alive KPCTRPRTH03 (231) K. pneumoniae 23/01/2017 In R R R R
32 OA ICU COL+MER Superinfection Death KPCTRPRTH04 (16) K. pneumoniae 17/04/2017 In R R R R
33 OA ICU COL+MER + LEV Response Alive KPCTRPRTH05 (16) K. pneumoniae 20/04/2017 In R R R R
  1. YA Young adult (18–39 years), OA Older adult (40–64 years), E Elderly (65+ years), IM Internal medicine ward, yrs. Years, ICU Intensive care unit, MER Meropenem, AMK Amikacin, COL Colistin, ERT Ertapenem, FOS Fosfomycin, PIP Piperacillin–tazobactam, TIG Tigecycline, GEN Gentamicin, LEV Levofloxacin, NR Nonresponse: worsening or persistence of clinical signs and/or symptoms of CPE infection, R Response: absence or improvement of all clinical signs and symptoms of CPE infection, SI Superinfection: second infection superimposed on an earlier one by different bacteria, Co Colonisation, In Infection, S Susceptible, I Intermediate, R Resistant
\